Pharmaceutical Executive May 17, 2024
Tala Fakhouri spoke at the conference about FDA’s approach to determining when it even needs to regulate the usage of AI in the pharma industry.
FDA is working on how it’s going to regulate AI.
The Financial Times hosted the US Pharma and Biotech Summit on May 16 in New York City. During the conference, associate director for policy analysis at FDA Tala Fakhouri participated in a session focused on how the agency is handling AI. According to Fakhouri, this is no easy task as the technology traverses the spectrum of technologies that FDA does and doesn’t regulate.
As such, the biggest issue FDA is considering is when to actually make rules about the usage of AI.
“We actually started...
Today's Sponsors
Today's Sponsor